Omarigliptin

CHEMBL2105762 Phase 4 معتمد Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

398.4 g/mol

LogP

0.3

Phase

4

A long-acting DPP-4 inhibitor taken once weekly to improve blood sugar control in adults with type 2 diabetes, available in Japan. It works by increasing levels of incretin hormones, which stimulate insulin release and suppress glucagon after meals.

الوزن الجزيئي

398,4000 g/mol

LogP

0,30

TPSA

98,80 Å²

قاعدة ليبينسكي للخمسة

ناجح

المجالات العلاجية

Type 2 Diabetes

Pharmacokinetics (PK)

Pharmacodynamics (PD)

البنية ثنائية الأبعاد

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)n1cc2c(n1)CN([C@H]1CO[C@H](c3cc(F)ccc3F)[C@@H](N)C1)C2

InChI

InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1

Molecular Formula

C17H20F2N4O3S

HBD / HBA

1 / 8

الروابط القابلة للدوران

3

الذرات الثقيلة

27

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A long-acting DPP-4 inhibitor taken once weekly to improve blood sugar control in adults with type 2 diabetes, available in Japan. It works by increasing levels of incretin hormones, which stimulate insulin release and suppress glucagon after meals.

Yes, Omarigliptin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105762. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 46209133. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

هل تبحث عن معلومات ملائمة للمرضى؟

Omarigliptin على PillFYI

البنية

بيانات سريعة

الصيغة الجزيئية: C17H20F2N4O3S

روابط خارجية

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.